{
    "title": "115_hr3382",
    "content": "The \"Youth Opioid Use Treatment Help Act of 2017\" or the \"YOUTH Act\" reauthorizes substance abuse treatment services for children, adolescents, and young adults. It includes access to medication-assisted treatment for adolescents and young adults through a demonstration program. The \"YOUTH Act\" authorizes grants for demonstration programs to expand access to medication-assisted treatment for opioid use disorders among adolescents and young adults, test solutions for implementation barriers, and provide resources for healthcare providers. Eligible entities include States, political subdivisions, and Indian tribes. To apply for a grant under the \"YOUTH Act,\" eligible entities must certify compliance with registration and licensing requirements and submit an application to the Director. Funds can be received to conduct a demonstration program as described in the Act. The \"YOUTH Act\" allows eligible entities to conduct a demonstration program for up to 3 years, with funding subject to review and approval by the Director. Recipients must submit progress reports as required. The Director will submit a report to the Committee on completed programs within one year. The Director will submit a report to the Committee on Health, Education, Labor, and Pensions of the Senate, and the Committee on Energy and Commerce of the House of Representatives, detailing the availability of medication-assisted treatment for adolescents and young adults with opioid use disorders in the United States, including barriers, specific demonstration programs, program effectiveness, unintended consequences, and recommendations for improving accessibility. The curr_chunk defines key terms related to opioid use disorders in adolescents and young adults, including medication-assisted treatment and pediatric health care providers. The curr_chunk defines terms related to professional family medicine and pediatric provider organizations and authorizes $5,000,000 for implementation."
}